Trial Profile
APB Study: Apixaban Pharmacokinetics in Bariatric Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Acronyms APB
- 17 Aug 2020 Status changed from recruiting to completed.
- 29 Jun 2020 Planned End Date changed from 1 Jun 2020 to 31 Aug 2020.
- 29 Jun 2020 Planned primary completion date changed from 1 Jun 2020 to 31 Aug 2020.